Primary Job Title Sr. VP Primary Organization 
Abbisko Therapeutics
Location China, Asia Regions Asia-Pacific (APAC) Gender Male
LinkedIn View on LinkedIn
Dr. Hongping Yu has worked in drug discovery and development in large pharmaceutical companies for over 15 years. He has successfully delivered more than a dozen of preclinical candidates across a wide range of therapeutic areas with many advanced into clinical development.
Prior to co-founding Abbisko, Dr. Yu served as the first head of
chemistry at Hansoh Pharmaceutical Company, built up the chemistry team, and led the discovery of multiple drug candidates including next generation inhibitors of EGFR, FXR, NS5A/B and others.
In previous positions, Dr. Yu worked as senior investigator at Novartis and research chemists at Merck.
Dr. Yu obtained his Ph.D. in organic chemistry from the University of British Columbia and B.S. & M.S. from Tsinghua University. He is a member of the China “Thousand Talent Program”.
